Public Health Warning against the Unapproved and Misleading Health Claims of Medical Devices That Decrease the Risk for Corona Virus Disease (COVID-19) Infection
The FDA Advisory No. 782-20 warns the public against unapproved medical devices making misleading health claims regarding their ability to reduce the risk of COVID-19 infection. It specifically targets products like the BioMask TM Flat+ TM and RespoKare Active Protection Mask, emphasizing that such masks cannot cure or eliminate viruses. The advisory stresses that there are currently no specific treatments for COVID-19 and encourages adherence to guidelines from the Department of Health and the World Health Organization. Marketing Authorization Holders are warned to cease misleading promotions, with regulatory action promised for non-compliance.
Law Information
- Reference Number
- FDA Advisory No. 782-20
- Date Enacted
- Subcategory
- Food and Drugs Administration of the Philippines
- Jurisdiction
- Philippines
- Enacting Body
- Congress of the Philippines
Full Law Text
May 7, 2020
FDA ADVISORY NO. 782-20
| TO | : | The General Public |
| SUBJECT | : | Public Health Warning against the Unapproved and Misleading Health Claims of Medical Devices That Decrease the Risk for Corona Virus Disease (COVID-19) Infection |
The Food and Drug Administration (FDA) warns the public against unapproved and misleading advertisements and promotion of various medical devices monitored as part of the post market surveillance activity of the Regional Field Office. HTcADC
Figure 1. Misleading health claims of BioMaskTM Flat+TM Medical Face Mask
Figure 2. Misleading health claims of RespoKare® Active Protection Mask Anti-Viral Mask
The public is hereby advised to be vigilant against such deceptive marketing of medical devices. Ear loop facemask shall not, in any way, cure and specially kill viruses and bacteria like influenza A and SARS and any other diseases, and should not bear any misleading, deceptive and false claims on their labels and/or any promotional materials that will provide erroneous impression on the product's character or identity. CAIHTE
Further, the FDA would like to emphasize that of this time, there are no specific treatments for COVID-19. Everyone is encouraged to follow accurate public health advice and guidance from the Department of Health and the World Health Organization on basic protective measures against COVID-19.
All Marketing Authorization Holders of these medical devices are sternly warned and hereby directed to stop such misleading advertisements and promotions. Appropriate regulatory tools and sanctions shall be executed to such companies that are continuously conducting such and other similar activities upon issuance of this Advisory. aScITE
Dissemination of this advisory to all concerned is hereby requested.
(SGD.) ROLANDO ENRIQUE D. DOMINGO, MDDirector General
Cite This Law
Public Health Warning against the Unapproved and Misleading Health Claims of Medical Devices That Decrease the Risk for Corona Virus Disease (COVID-19) Infection, FDA Advisory No. 782-20, May 7, 2020 (Philippines)
Public Health Warning against the Unapproved and Misleading Health Claims of Medical Devices That Decrease the Risk for Corona Virus Disease (COVID-19) Infection, FDA Advisory No. 782-20 (Phil. 2020)
Related Laws
- Public Health Warning against the Purchase and Use of Disinfectants/Biocides Products with Misleading Health Claims That Decrease the Risk for Corona Virus Disease (COVID-19) InfectionFDA Advisory No. 852-20 • May 15, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Public Health Warning against the Unapproved and Misleading Advertisement of Food Products and Food Supplements Claiming to Boost Immune System and Decrease the Risk for Coronavirus Disease (COVID)-19 InfectionFDA Advisory No. 531-20 • Apr 3, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Compendium of Department of Health Issuances on Infection Prevention and Control in the Health Facilities in the Context of Corona Virus Disease 2019 (COVID-19)DOH Department Circular No. 2020-0298 • Jul 3, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Reiteration of the Amendment of the Updated List for the Price Freeze of Essential Emergency Medicines and Medical Devices Due to the Corona Virus Disease 2019 (COVID-19) Health EventDOH Department Circular No. 2020-0186 • Apr 15, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Use of World Health Organization Interim Guidelines for Health Workers Exposure Risk Assessment and Management in the Context of COVID-19 VirusDOH Department Circular No. 2020-0106 • Mar 6, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
- Resolutions Relative to the Management of the Corona Virus Disease 2019 (COVID-19) SituationIATF-EID Resolution No. 015, s. 2020 • Mar 24, 2020 • Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Browse More Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances
Explore other laws in the Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) Issuances category.
View All Inter-Agency Task Force on Emerging Infectious Diseases (IATF-EID) IssuancesNeed Help Understanding This Law?
Ask our AI assistant to explain provisions, implications, or related laws.
Ask AI About This Law